Both in Pharmaceuticals
Oramed Pharmaceuticals vs BridgeBio Oncology Therapeutics
Over the past year ORMP returned +81.1% and BBOT returned −81.0%; their daily moves had a correlation of 0.26.
ORMP +81.1% BBOT −81.0%Growth of $1, one year, split-adjusted
| Metric | ORMP | BBOT |
|---|---|---|
| Price | $4.13 | $2.30 |
| Market cap | $171.8M | $184.4M |
| Today | +3.25% | −0.86% |
| 1 month | −5.7% | −34.3% |
| 6 months | +5.4% | −72.4% |
| Year to date | +44.9% | −81.6% |
| 1 year | +75.0% | −81.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.0× | — |
| Price / sales | — | — |
| Net cash | $50.6M | $225.7M |
| Dividend yield | 6.05% | — |
| Volatility (60d) | 36.4% | 87.9% |
| Short % of float | 4.3% | 13.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).